Background Although well-differentiated papillary thyroid cancer may remain indolent,
lymph node metastases and the recurrence rates are approximately 50% and 20 …

Background Although papillary thyroid cancer (PTC) patients are known to have an
excellent prognosis, up to 30% of patients experience disease recurrence after initial …

Simple Summary Some thyroid tumors elected for surveillance remain indolent, while others
progress. The mechanism responsible for this difference is poorly understood, making it …

The current focus in the treatment of papillary thyroid carcinoma (PTC) is tumor progression.
The aim of this study was to build RNA-based classifiers and develop a comprehensive …

Context Clinical applications of genomic assessment of thyroid cancers are rapidly evolving.
Objectives, Design, and Setting We studied tumor samples from patients with imminently …

Simple Summary Papillary thyroid cancer (PTC) patients are staged according to the Tumor-
Node-Metastasis staging system (TNM). This work was aimed at comparing the usefulness …

Background: The incidence of papillary thyroid carcinoma (PTC) is high and increasing
worldwide. Although prognosis is relatively good, it is important to select the minority of …

Though many patients with thyroid cancer may be indolent, there are still about 50% lymph
node metastases and 20% the recurrence rates. There is still no ideal method to predict its …

Thyroid cancer (TC) is the most common endocrine malignancy, with an incidence
continuing to grow every year. Although thyroid cancer as a whole is generally indolent and …

Thyroid cancer is the most prevalent endocrine malignancy that comprises mostly indolent
differentiated cancers (DTCs) and less frequently aggressive poorly differentiated (PDTC) or …